2025 · 4th Quarter (Oct 1 - Dec 31)

FERRING PHARMACEUTICALS, INC.

Filed by FERRING PHARMACEUTICALS, INC..

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 15, 2026
Income: Not reported
Expenses: $290,000.00
Registrant: FERRING PHARMACEUTICALS, INC.
Client: FERRING PHARMACEUTICALS, INC.
Filing UUID: 3d3643ea-ee73-406d-a94d-6ff942e07c15
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to fertility treatment and coverage (no bill); issues related to federal employee health care coverage (Family Building FEHB Fairness Act, H.R. 1670 / S. 797), issues related to veterans health coverage (Veterans Infertility Treatment Act, H.R. 220 / no Senate bill), issues related to infertility coverage for members of the military included in the National Defense Authorization Act (S. 2296, Sec. 705 / H.R. 3838, Sec. 703), issues related to access to cancer treatments (Protecting Patient Access to Cancer and Complex Therapies Act, H.R. 4299 / no Senate bill).

Literal federal measure citations: H.R. 1670, S. 797, H.R. 220, S. 2296, H.R. 3838, H.R. 4299

TAX · Taxation/Internal Revenue Code

Issues related to establishing a tax credit for fertility treatments (IVF Access and Affordability Act, H.R. 1878 / no Senate bill; Infertility Treatment Affordability Act, H.R.4639 / no Senate bill).

Literal federal measure citations: H.R. 1878, H.R.4639

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.